Furthermore, similar to pasireotide, RA-9 was able to significantly reduce phospho- ERK1/2 levels in both AtT-20 cells and primary cultured cells from corticotropinomas [39]. The gene discussed is MAPK3; the disease is ACTH-producing pituitary gland adenoma.